Progress on contraception methods of perimenopausal women

( views:94, downloads:0 )
LIU Wei-hua(Family Planning Department of Taishan Medical College,Taian 271000,China)
SUN Yan-ling()
GAO Dan-feng(Family Planning Department of Taishan Medical College,Taian 271000,China)
Journal Title:
Volume 29, Issue 01, 2010
10.3760/cma j.issn.1673-4351.2010.01.002
Key Word:
Perimenopause;Contraception methods

Abstract: This article introduced the progress on perimenopause contraception. Various contraceptive options may be offered to perimenopausal women, including oral contraceptives, tubal ligation, intrauterine devices, barrier methods, hormonal injectables and implants. Recently, new methods of contraception have been introduced presenting high efficacy rates and minor side - effect, such as the monthly injectable system, the contraceptive vaginal ring and the transderimal contraceptive system. The use of the various contraceptive methods during perimenopause holds special benefits and risks that should be carefully balanced, after a thorough consultation and according to each women(s) contraception needs.

  • [1]Kailas NA,Sifakis S.Koumantakis E.Contraception during perimenopause[J].Eur J Contracept Reprod Heath Care,2005,10 (1):19-25.
  • [2]Andersen AM,Wohlfahrt J,Christens P,et al.Maternal age and fetal loss:population based register linkage study[J].BMJ,2000,320(7251):1708-1712.
  • [3]汤新梅.更年期妇女妊娠的危险性与避孕方法选择[J].中国民康医学,2007,19(24):1118.
  • [4]Kaunitz AM.Current concepts regarding use of DMPA[J].J Reprod Med,2002,47 (Suppl):785-789.
  • [5]Smith JS,Green J,Berrington E,et al.Cervical cancer and use of hormonal contraceptives:a systematic review[J].Lancet,2003,361(9364):1159-1167.
  • [6]Moreno V,Bosch FX,Munoz N,et al.Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection:the IARC multicentric case-control study[J].Lancet,2002,359(9312):1085-1092.
  • [7]Shumaker SA,Lenault C,Rapp SR,et al.Estrogen plus progestin and the incidence of dementia and mildcosnitive impairment in postmenopausal women:the women,s health initiative memory study:a randomized controlled trial[J].JAMA,2003,289 (20):2651-2662.
  • [8]Purdie DM,Bain CJ,Siskind V,et al.Ovulation and risk of epithelial ovarian cancer[J].lnt J Cancer,2003,20 (104):228-232.
  • [9]江静.患有和末患子宫内膜异位症妇女口服避孕药、生育史与发生卵巢上皮性癌危险性的研究[J].国外医学计划生育生殖健康分册,2006,25(2):118-119.
  • [10]Modan B,Hartge P,Yechezkal G,et al.Parity,oral contraceptives,and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation[J].N Engl J Med,2001,26 (345):235-240.
  • [11]Fernandez E,Vecchia C,Balducci A,et al.Oral contraceptives and colorectal cancer risk:a meta-analysis[J].Br J Cancer,2001,84 (5):722-727.
  • [12]马薇,周昌菊.围绝经期妇女应用口服避孕药的问题与思考[J].医学与社会,2006,19(4):13-15.
  • [13]乐杰,谢幸,丰有吉.妇产科学[M].北京:人民卫生出版社,2004:395.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615